“…Other promising genome engineering approaches include retron-associated recombineering, which uses the bacterial retron reverse transcriptase to continuously produce mutagenic oligos in vivo ( Lopez et al, 2022 ; Schubert et al, 2021 ), as well as synthetic base editing enzymes ( Gaudelli et al, 2017 ; Komor et al, 2016 ; Mok et al, 2020 ) and prime-editing enzymes ( Anzalone et al, 2019 ). I am also excited by the recent work of Ding, et al, who showed that yeast harboring a Sindbis virus cDNA driven by the strong, galactose-inducible Gal1 promoter can produce infectious transcripts and initiate replication upon fusion of the induced yeast with mammalian cells, thereby avoiding the need to isolate a cDNA and transcribe RNA in vitro ( Ding et al, 2021 ). I imagine a nearby future whereby nearly all standard molecular virology may be outsourced to yeast: we will be able to program yeast to create mutants of interest, such as with eMAGE, and to then produce infectious RNAs by feeding them galactose ( Fig.…”